Literature DB >> 22880539

Chronic pain and addiction: challenging co-occurring disorders.

Mel Pohl1, Logan Smith.   

Abstract

Chronic pain is commonly treated by prescribing an opioid medication. For those suffering from both chronic pain and substance dependence, barriers to adequate pain management increase. This often causes both disorders to exacerbate one another. Effective treatment may also be hampered by opioid-induced hyperalgesia, tolerance, physical dependence, "chemical coping," and diminished physical and emotional functioning. This article reviews current research trends, potential problems stemming from prescription opioid use, and suggestions for clinical practice.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22880539     DOI： 10.1080/02791072.2012.684621

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN： 0279-1072


  12 in total

1.  Persistent pain facilitates response to morphine reward by downregulation of central amygdala GABAergic function.

Authors:  Zhi Zhang; Wenjuan Tao; Yuan-Yuan Hou; Wei Wang; Yun-Gang Lu; Zhizhong Z Pan
Journal:  Neuropsychopharmacology       Date:  2014-04-01       Impact factor: 7.853

2.  Prevalence and experience of chronic pain in suburban drug injectors.

Authors:  Robert Heimer; Weihai Zhan; Lauretta E Grau
Journal:  Drug Alcohol Depend       Date:  2015-03-19       Impact factor: 4.492

3.  Evaluation and comparison of tools for diagnosing problematic prescription opioid use among chronic pain patients.

Authors:  Merav Kovatch; Daniel Feingold; Odelia Elkana; Shaul Lev-Ran
Journal:  Int J Methods Psychiatr Res       Date:  2016-10-23       Impact factor: 4.035

4.  Peripherally Selective Cannabinoid 1 Receptor (CB1R) Agonists for the Treatment of Neuropathic Pain.

Authors:  Herbert H Seltzman; Craig Shiner; Erin E Hirt; Anne F Gilliam; Brian F Thomas; Rangan Maitra; Rod Snyder; Sherry L Black; Purvi R Patel; Yatendra Mulpuri; Igor Spigelman
Journal:  J Med Chem       Date:  2016-08-10       Impact factor: 7.446

5.  A Pilot Study To Define Chemical Coping in Cancer Patients Using the Delphi Method.

Authors:  Jung Hye Kwon; David Hui; Eduardo Bruera
Journal:  J Palliat Med       Date:  2015-04-29       Impact factor: 2.947

Review 6.  The Mesolimbic Dopamine System in Chronic Pain and Associated Affective Comorbidities.

Authors:  Randal A Serafini; Kerri D Pryce; Venetia Zachariou
Journal:  Biol Psychiatry       Date:  2020-01-01       Impact factor: 13.382

Review 7.  The downward spiral of chronic pain, prescription opioid misuse, and addiction: cognitive, affective, and neuropsychopharmacologic pathways.

Authors:  Eric L Garland; Brett Froeliger; Fadel Zeidan; Kaitlyn Partin; Matthew O Howard
Journal:  Neurosci Biobehav Rev       Date:  2013-08-26       Impact factor: 8.989

8.  A pain-induced tonic hypodopaminergic state augments phasic dopamine release in the nucleus accumbens.

Authors:  Taylor A Gee; Nathan C Weintraub; Dong Lu; Caroline E Phelps; Edita Navratilova; Michael L Heien; Frank Porreca
Journal:  Pain       Date:  2020-10       Impact factor: 7.926

9.  The impact of chronic pain on opioid addiction treatment: a systematic review protocol.

Authors:  Brittany B Dennis; Monica Bawor; James Paul; Michael Varenbut; Jeff Daiter; Carolyn Plater; Guillaume Pare; David C Marsh; Andrew Worster; Dipika Desai; Lehana Thabane; Zainab Samaan
Journal:  Syst Rev       Date:  2015-04-16

Review 10.  Impact of Chronic Pain on Treatment Prognosis for Patients with Opioid Use Disorder: A Systematic Review and Meta-analysis.

Authors:  Brittany B Dennis; Monica Bawor; Leen Naji; Carol K Chan; Jaymie Varenbut; James Paul; Michael Varenbut; Jeff Daiter; Carolyn Plater; Guillaume Pare; David C Marsh; Andrew Worster; Dipika Desai; Lehana Thabane; Zainab Samaan
Journal:  Subst Abuse       Date:  2015-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.